OAM
SGNT

Oxford Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Oxford Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-152,817
Closed -$2.29M – 948
2016
Q2 		$2.29M Buy
152,817
+121,945
+395% +$1.57M 0.08% 342
2016
Q1 		$376K Buy
+30,872
New +$433K 0.01% 651
2015
Q3 		– Sell
-140,684
Closed -$3.42M – 784
2015
Q2 		$3.42M Buy
140,684
+72,730
+107% +$1.74M 0.09% 240
2015
Q1 		$1.58M Sell
67,954
-68,195
-50% -$1.8M 0.04% 396
2014
Q4 		$3.43M Buy
136,149
+65,466
+93% +$1.92M 0.08% 261
2014
Q3 		$2.2M Sell
70,683
-14,285
-17% -$387K 0.05% 353
2014
Q2 		$2.18M Buy
+84,968
New +$1.89M 0.07% 357
2014
Q1 		– Sell
-124,065
Closed -$3.15M – 853
2013
Q4 		$3.15M Sell
124,065
-138,343
-53% -$3.12M 0.08% 336
2013
Q3 		$5.35M Buy
262,408
+227,866
+660% +$5.07M 0.12% 222
2013
Q2 		$725K Buy
+34,542
New +$617K 0.02% 640

Oxford Asset Management's SGNT Position: Q3 2016 in Review

Oxford Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 152,817 shares — an estimated $2.29M sold.

Oxford Asset Management first reported a position in SGNT in Q2 2013 and held it in 10 quarters. The position peaked at $5.35M in Q3 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Oxford Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Oxford Asset Management sold 152,817 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $2.29M.
  • Oxford Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 10 quarters.
  • Oxford Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $5.35M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Oxford Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.